BMC Clinical Pharmacology

unofficial impact factor 1.36
Search for
Advanced search
BMC Clinical Pharmacology
Tools
Share this article
Open Access Email this article to a friend

Does atenolol differ from other β-adrenergic blockers?

Ivar Aursnes*, Jan-Bjørn Osnes, Ingunn F Tvete, Jørund Gåsemyr and Bent Natvig

BMC Clinical Pharmacology 2007, 7:4 doi:10.1186/1472-6904-7-4

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.